ArticlePloS one2012

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.

Charles Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.